Assessing the Ability of Combination Treatment With Venetoclax to Permit Time Limited Therapy in Chronic Lymphocytic Leukemia
Clinical trial NCT03701282 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03701282
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-12
- Primary completion
- 2028-05-07
- Enrollment
- 720
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.